These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 26492394)

  • 1. Control of Immune Response to Allogeneic Embryonic Stem Cells by CD3 Antibody-Mediated Operational Tolerance Induction.
    Calderon D; Prot M; You S; Marquet C; Bellamy V; Bruneval P; Valette F; de Almeida P; Wu JC; Pucéat M; Menasché P; Chatenoud L
    Am J Transplant; 2016 Feb; 16(2):454-67. PubMed ID: 26492394
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Donor-Specific Regulatory T Cell-Mediated Immune Tolerance in an Intrahepatic Murine Allogeneic Islet Transplantation Model with Short-Term Anti-CD154 mAb Single Treatment.
    Lee SJ; Kim HJ; Byun NR; Park CG
    Cell Transplant; 2020; 29():963689720913876. PubMed ID: 32216448
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tolerance induction to human stem cell transplants with extension to their differentiated progeny.
    Lui KO; Howie D; Ng SW; Liu S; Chien KR; Waldmann H
    Nat Commun; 2014 Dec; 5():5629. PubMed ID: 25434740
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of allograft tolerance by monoclonal CD3 antibodies: a matter of timing.
    You S; Zuber J; Kuhn C; Baas M; Valette F; Sauvaget V; Sarnacki S; Sawitzki B; Bach JF; Volk HD; Chatenoud L
    Am J Transplant; 2012 Nov; 12(11):2909-19. PubMed ID: 22882762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Host CD40 ligand deficiency induces long-term allograft survival and donor-specific tolerance in mouse cardiac transplantation but does not prevent graft arteriosclerosis.
    Shimizu K; Schönbeck U; Mach F; Libby P; Mitchell RN
    J Immunol; 2000 Sep; 165(6):3506-18. PubMed ID: 10975872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ectopic expression of recipient CD47 inhibits mouse macrophage-mediated immune rejection against human stem cell transplants.
    Leung CS; Li J; Xu F; Wong ASL; Lui KO
    FASEB J; 2019 Jan; 33(1):484-493. PubMed ID: 30004796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costimulation-adhesion blockade is superior to cyclosporine A and prednisone immunosuppressive therapy for preventing rejection of differentiated human embryonic stem cells following transplantation.
    Huber BC; Ransohoff JD; Ransohoff KJ; Riegler J; Ebert A; Kodo K; Gong Y; Sanchez-Freire V; Dey D; Kooreman NG; Diecke S; Zhang WY; Odegaard J; Hu S; Gold JD; Robbins RC; Wu JC
    Stem Cells; 2013 Nov; 31(11):2354-63. PubMed ID: 24038578
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Embryonic stem cells, derived either after in vitro fertilization or nuclear transfer, prolong survival of semiallogeneic heart transplants.
    Imberti B; Casiraghi F; Cugini D; Azzollini N; Cassis P; Todeschini M; Solini S; Sebastiano V; Zuccotti M; Garagna S; Redi CA; Noris M; Morigi M; Remuzzi G
    J Immunol; 2011 Apr; 186(7):4164-74. PubMed ID: 21389254
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New generation CD3 monoclonal antibodies: are we ready to have them back in clinical transplantation?
    You S; Chatenoud L
    Curr Opin Organ Transplant; 2010 Dec; 15(6):720-4. PubMed ID: 20881491
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Embryonic stem cell immunogenicity increases upon differentiation after transplantation into ischemic myocardium.
    Swijnenburg RJ; Tanaka M; Vogel H; Baker J; Kofidis T; Gunawan F; Lebl DR; Caffarelli AD; de Bruin JL; Fedoseyeva EV; Robbins RC
    Circulation; 2005 Aug; 112(9 Suppl):I166-72. PubMed ID: 16159810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Idarubicin-anti-CD3: a new immunoconjugate that induces alloantigen-specific tolerance in mice.
    Mottram PL; Han WR; Murray-Segal LJ; Mandel TE; Pietersz GA; McKenzie IF
    Transplantation; 1997 Sep; 64(5):684-90. PubMed ID: 9311703
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idarubicin-145-2C11-F(ab')2 promotes peripheral tolerance and reduces chronic vascular disease in mouse cardiac allografts.
    Han WR; Murray-Segal LJ; Gershenzon A; Zhang JG; Hodder AN; Pietersz GA; Mottram PL
    Transpl Immunol; 1999 Dec; 7(4):207-13. PubMed ID: 10638833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. T-cell depletion and graft survival induced by anti-human CD3 immunotoxins in human CD3epsilon transgenic mice.
    Weetall M; Digan ME; Hugo R; Mathew S; Hopf C; Tart-Risher N; Zhang J; Shi V; Fu F; Hammond-McKibben D; West S; Brack R; Brinkmann V; Bergman R; Neville D; Lake P
    Transplantation; 2002 May; 73(10):1658-66. PubMed ID: 12042656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Induction of specific tolerance to allografts in rats by therapy with non-mitogenic, non-depleting anti-CD3 monoclonal antibody: association with TH2 cytokines not anergy.
    Plain KM; Chen J; Merten S; He XY; Hall BM
    Transplantation; 1999 Feb; 67(4):605-13. PubMed ID: 10071035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Anti-CD2 and anti-CD3 monoclonal antibodies synergize to prolong allograft survival with decreased side effects.
    Chavin KD; Qin L; Lin J; Kaplan AJ; Bromberg JS
    Transplantation; 1993 Apr; 55(4):901-8. PubMed ID: 8097344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that anti-CD8 abrogates anti-CD4-mediated clonal anergy but allows allograft survival in mice.
    Song HK; Alters SE; Fathman CG
    Transplantation; 1993 Jan; 55(1):133-9. PubMed ID: 8420037
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of long-term specific tolerance to allografts in rats by therapy with an anti-CD3-like monoclonal antibody.
    Nicolls MR; Aversa GG; Pearce NW; Spinelli A; Berger MF; Gurley KE; Hall BM
    Transplantation; 1993 Mar; 55(3):459-68. PubMed ID: 8456460
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice.
    Chatenoud L; Thervet E; Primo J; Bach JF
    Proc Natl Acad Sci U S A; 1994 Jan; 91(1):123-7. PubMed ID: 8278351
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Progress towards the clinical use of CD3 monoclonal antibodies in the treatment of autoimmunity.
    Chatenoud L
    Curr Opin Organ Transplant; 2009 Aug; 14(4):351-6. PubMed ID: 19610168
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lack of immune response to differentiated cells derived from syngeneic induced pluripotent stem cells.
    Guha P; Morgan JW; Mostoslavsky G; Rodrigues NP; Boyd AS
    Cell Stem Cell; 2013 Apr; 12(4):407-12. PubMed ID: 23352605
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.